Health News Archive - June 27, 2010
A German court has ruled that a dying person has the right to have life support turned off if that person has given their consent.
SAN DIEGO, June 27 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc.
Journeys across several time zones make our internal body clocks go haywire.
A new study shows that use of psychotropic medications during pregnancy increase the probability of birth defects.
GREAT FALLS, Va. and OAK BROOK, Ill., June 28 /PRNewswire/ -- AcuStream, LLC (AcuStream) and the University HealthSystem Consortium (UHC) today announced that they have entered into a partnership to deliver a cobranded version of AcuStream's RevBuilder(TM) service to UHC's members.
NEW YORK and JERUSALEM, June 28 /PRNewswire/ -- Chiasma, Inc., a privately held biopharma company, announced that the Food and Drug Administration (FDA) has granted orphan drug designation for Chiasma's investigational new drug, Octreolin, an oral form of octreotide acetate that uses the Company's proprietary Transient Permeability Enhancer (TPE) technology for the oral treatment of acromegaly, a hormonal disorder that results from an excess of growth hormone. If a New Drug Application (NDA) is approved, Octreolin should qualify for seven years of market exclusivity, potential tax credits, and a waiver of the prescription drug user fee for the marketing application. Chiasma has successfully completed a Phase I clinical study evaluating the safety and pharmacokinetics (PK) of Octreolin, which demonstrated a PK profile similar to that of subcutaneously injected octreotide acetate.
OAKLAND, Calif., June 28 /PRNewswire/ -- The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and the varicella (V) vaccine for chicken pox, according to a Kaiser Permanente Division of Research study appearing online in the journal Pediatrics.
- The prevailing range of a vocal or instrumental part, within which most of the tones lie.